UTI MNC Fund · Regular · Growth
NAV
₹395.9528
as of 13 Nov 2026
Expense Ratio
2.16%
AUM
₹2,745 Cr
Lumpsum returns (CAGR)
- 1Y
- -2.84%
- 3Y
- +8.34%
- 5Y
- +6.70%
- Since Inception
- +13.99%
SIP returns (XIRR)
- 1Y
- +2.94%
- 3Y
- +3.26%
- 5Y
- +7.33%
- Since Inception
- +13.09%
Returns calculated from 14 August 2018 onwards due to a structural change in the scheme on that date. Earlier NAV history is preserved but excluded from multi-year return calculations. Periods spanning this date show —.
What history actually did — last 10 years (Nov 2016 – Nov 2026)
A ₹5,000 monthly SIP for the last 10 years (Nov 2016 – Nov 2026)
Real NAV backtest
A ₹5,000 monthly SIP would be worth ₹9,67,125 today — ₹6,00,000 invested, 9.3% XIRR.
₹6,00,000
Invested
₹9,67,125
Value today
9.3%
XIRR (p.a.)
A ₹1,00,000 lumpsum, the last 10 years (Nov 2016 – Nov 2026)
Real NAV backtest
₹1,00,000 invested 10 years ago would be ₹2,74,834 today (10.6% CAGR).
A regular withdrawal plan (SWP)
Real NAV backtest
A ₹10,00,000 corpus withdrawing ₹5,000/month since Nov 2016 would still hold ₹17,81,219.
Fund vs Benchmark (TRI)
Same SIP, benchmark total-return index
The same SIP would be worth ₹9,67,125 in this fund vs ₹11,99,859 in the benchmark — underperformance of ₹2,32,734.
Buying the worst day
Real NAV backtest
₹1,00,000 invested on the worst market day of the last 10 years (Nov 2016 – Nov 2026) (22 Mar 2020) would be ₹2,74,404 today (2.74×).
Historical simulation using actual published NAVs for the stated period. Past performance may or may not be sustained in the future. Not investment advice.
Risk Metrics
Trailing 1 year, annualised-0.22
Sharpe Ratio
-0.01
Alpha
0.77
Beta
-0.20
Sortino
11.54%
Std Dev
-14.94%
Max Drawdown
Performance Comparison
Sectoral allocation
as of 31 Oct 2026- Pharmaceuticals & Biotechnology17.62%
- Auto Components12.53%
- Automobiles10.54%
- IT - Software10.13%
- Industrial Products5.85%
- Diversified FMCG4.85%
- Food Products4.32%
- Consumer Durables3.44%
- Non - Ferrous Metals2.60%
- Personal Products2.39%
- Chemicals & Petrochemicals2.19%
- Finance2.15%
Each sector links to the mutual funds most exposed to it.
Related reading
Thinking about UTI MNC Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Fund Details
Available transactions
Portfolio holdings
- 1Maruti Suzuki India Ltd.7.07%
- 2Bosch Ltd.5.25%
- 3Hindustan Unilever Ltd4.85%
- 4Gland Pharma Ltd.4.52%
- 5Nestle India Ltd.4.32%
- 6Proctor & Gamble Health Ltd4.25%
- 7Hyundai Motor India Ltd3.47%
- 8Lg Electronics India Ltd2.62%
- 9Coforge Ltd2.62%
- 10Vedanta Aluminium Metal Ltd.2.60%
What this fund does
UTI MNC Fund · Regular · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
UTI MNC Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by UTI Mutual Fund. The fund has been operational for over 21 years. It manages assets worth ₹2,745 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against BSE 200 TRI. The current expense ratio is 2.16%.
Who Should Invest?
- •Aggressive investors comfortable with significant short-term volatility
- •Investors with a long-term horizon of 7+ years who can ride out market cycles
- •SIP investors who can benefit from rupee cost averaging during market fluctuations